Surmodics Q1 Adjusted EPS $0.00 May Not Be Comparable To $(0.30) Estimate, Sales $30.55M Beat $29.64M Estimate

Author: Benzinga Newsdesk | February 01, 2024 08:02am
Surmodics (NASDAQ:SRDX) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.30) by 100.33 percent. This is a 100.2 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $30.55 million which beat the analyst consensus estimate of $29.64 million by 3.08 percent. This is a 22.54 percent increase over sales of $24.93 million the same period last year.

Posted In: SRDX